October 24, 2016 10:08 AM ET

Life Sciences Tools and Services

Company Overview of Accelovance, Inc.

Company Overview

Accelovance, Inc., a contract research organization (CRO), provides site management organization, patient recruitment, and clinical call center services. The company focuses on oncology, vaccines, and general medicine to pharmaceutical and biotech industries. Its CRO services include protocol development, project management, clinical trial monitoring, data management, biostatistics, pharmacovigilance, regulatory affairs, and medical writing services. The company also provides clinical call center services, such as recruitment/retention/compliance, post approval safety studies, phase IV studies, surveillance programs, patient-reported outcomes, observational studies, registries, site support ...

2275 Research Boulevard

Suite 700

Rockville, MD 20850

United States

Founded in 2004





Key Executives for Accelovance, Inc.

Founder, Chief Executive Officer and President
Age: 62
Chief Financial Officer
Chief Operating Officer
Managing Director of Accelovance China
Managing Executive Director of Accelovance Europe
Compensation as of Fiscal Year 2016.

Accelovance, Inc. Key Developments

Accelovance, Inc. and FHI 360 Enters into Strategic Alliance

Accelovance, Inc. and FHI 360 entered into a strategic alliance to more comprehensively serve the international drug development research efforts of pharmaceutical, governmental, and nonprofit organizations. The strategic alliance expands Accelovance's service offering and capabilities in developing countries in Africa, Asia Pacific, and South America, and expands FHI's capabilities and coverage in North America and Europe. Both CRO’s have been collaborating on projects in several regions of the world, most notably on a large Phase III Ebola vaccine trial in Sierra Leone. This strategic alliance enables both companies to expand their global footprint and support the full program drug development needs of pharmaceutical, governmental, and nonprofit organizations.

Accelovance, Inc. Appoints Mark S. Gelder as Vice President of Medical Affairs, Oncology

Accelovance, Inc. announced that Mark S. Gelder has joined the company as Vice President Medical Affairs, Oncology. Gelder brings more than 25 years of oncology clinical trial and drug development experience to the company, having provided significant contributions in the investigation, approval, and postmarketing development of multiple products.

Midwest Melanoma Partnership and Accelovance, Inc. Enhance Melanoma Research Offering Through Strategic Alliance

Accelovance, Inc. and the Midwest Melanoma Partnership have entered into a strategic alliance to enhance the research and advancement of treatment options for patients suffering from melanoma. The strategic alliance provides pharmaceutical and biotechnology companies with enhanced access to melanoma key opinion leaders, expedited contracting and protocol review within MMP's 19 academic and community-based research center members, and Accelovance's oncology-experienced clinical and project staff within the United States and Europe.

Similar Private Companies By Industry

Company Name Region
10X Genomics, Inc. United States
4G Clinical, Inc. United States
AAPharmaSyn LLC United States
Abiant, Inc. United States
aBioBot, Inc. United States

Recent Private Companies Transactions

December 2, 2015
Clinquest Europe BV

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Accelovance, Inc., please visit www.accelovance.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.